Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 6Tumor-Agnostic 3Other solid neoplasm 3Gastrointestinal 3Classical hematology 3Lymphoid 2Head & Neck 2Other neoplasm 1Gynecologic 1

Conditions

Malignant Neoplasmas 1

Interventions

Gemcitabine 2Aminolevulinic Acid 2toripalimab 1tirbanibulin 1ruxolitinib 1potassium oxonate 1penpulimab 1human papillomavirus vaccine, L1 type 16, 18 1gimeracil 1apatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Toremifene 1Tegafur 1Robotic Surgical Procedures 1Rifampin 1RAD140 1Pregnancy Tests 1Pemetrexed 1ON 01910 1Nivolumab 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hysterectomy 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Excipients 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × ON 01910 × Other neoplasm × Clear all
NCT01125891 2017-06-23

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Traws Pharma, Inc.

Phase 1 Completed
39 enrolled
Other neoplasmOther solid neoplasm

Malignant Neoplasmas

Data powered by HemOnc (CC BY 4.0) Colophon âš¡